EPoS - Elucidating Pathways of Steatohepatitis

Non-Alcoholic Fatty Liver Disease (NAFLD) is an increasingly common cause of advanced liver disease in the aging population of Europe. Up to 30% of the EU population have NAFLD, which will be the main reason for liver transplants by 2020. However, NAFLD is characterized by substantial, and unexplained, inter-patient variability in severity and rate of progression.

The overall EPoS concept is that improved understanding of pathogenic processes and drivers of disease progression will best be achieved when multiple ‘omics’ approaches are applied to a single cohort of patients to build a multi-dimensional record of how systems are perturbed across the entire spectrum of disease. Once completed, EPoS promises to deliver a substantial and definitive atlas of pathophysiological variation across a spectrum of progressive liver disease.

The EPoS project started on 1st May 2015 and is due to run for a period of 4 years. It has 10 partners from 6 different countries. EPoS is funded by the EU Horizon 2020 Programme (Project No. 634413).

H2020 Topic: PHC-01-2014
Total cost: € 6.17M, EC funding: € 5.99M



RAIS - Scalable, point-of-care and label free microarray platform for rapid detection of Sepsis

The overall objective of the RAIS project is to develop a new point-of-care, label-free microarray platform, based on a proprietary interferometric lens-less microscopy design, which overcomes existing problems, and to validate the system for quantifying levels of specific Sepsis biomarkers within 30 minutes.

The RAIS project started on 1st January 2015 and is due to run for a period of 3 years. It has 9 partners from 6 different countries. RAIS is funded by the EU Horizon 2020 Programme (Project No. 644956).

H2020 Topic: ICT-26-2014 Photonics KET
Total cost: € 3.39M, EC funding: € 2.99M